Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy: a systematic review and meta-analysis

2018 ◽  
Vol 20 (11) ◽  
pp. 1430-1438 ◽  
Author(s):  
L. Darvish ◽  
M. Ghorbani ◽  
S. Hosseini Teshnizi ◽  
N. Roozbeh ◽  
F. Seif ◽  
...  
2017 ◽  
Vol 122 (3) ◽  
pp. 423-430 ◽  
Author(s):  
Jie Lee ◽  
Kai-Lung Hua ◽  
Shih-Ming Hsu ◽  
Jhen-Bin Lin ◽  
Chou-Hsien Lee ◽  
...  

2011 ◽  
Vol 47 ◽  
pp. S366
Author(s):  
P. Porcu ◽  
I. Meaglia ◽  
P. Tabarelli ◽  
M. Liotta ◽  
G.B. Ivaldi

2018 ◽  
Vol 63 (1) ◽  
pp. 102-115 ◽  
Author(s):  
Harriet E Gee ◽  
Lauren Moses ◽  
Kirsty Stuart ◽  
Najmun Nahar ◽  
Ken Tiver ◽  
...  

2018 ◽  
Vol 126 (1) ◽  
pp. 148-154 ◽  
Author(s):  
Marianne C. Aznar ◽  
Frances K. Duane ◽  
Sarah C. Darby ◽  
Zhe Wang ◽  
Carolyn W. Taylor

Author(s):  
Julie B. Schnur ◽  
Bianca Love ◽  
Bari L. Scheckner ◽  
Sheryl Green ◽  
A. Gabriella Wernicke ◽  
...  

2013 ◽  
Vol 12 (1) ◽  
pp. 31-44
Author(s):  
Athanasios Tzikas ◽  
Georgios Komisopoulos ◽  
Brigida Costa Ferreira ◽  
Simo Hyödynmaa ◽  
Sofie Axelsson ◽  
...  

2021 ◽  
Author(s):  
Bushra Zareie ◽  
Mohammad Aziz Rasouli ◽  
Jalal Poorolajal

Abstract Background: Epidemiological studies have shown that the risk of secondary malignancies may increase by radiotherapy. Lung cancer is the most important long-term complication of breast cancer radiotherapy.Methods: Major electronic databases including Scopus, Web of Science, and MEDLINE were searched. All cohort studies that investigated the association between radiotherapy for breast cancer and risk of primary lung, bronchus and trachea cancers conducted until March 2021 were included. The study participants were evaluated regardless of their age and ethnicity. The Newcastle-Ottawa Scale was used to assess the quality of the studies. The designated effects were risk ratio (RR). The random-effects model was used to estimate the average effects.Results: Fifteen studies including 1,640,247 women with primary breast cancer were identified of which 937,151 had not received radiotherapy and 703,096 subjects had received radiotherapy. In general, there was no significant association between breast cancer radiotherapy and lung cancer based on 10 studies (RR=0.95, 95%CI: 0.87-1.02, P=0.15), There was no association between breast cancer radiotherapy and lung, bronchus, and trachea cancers either based on 5 studies (RR=0.98, 95%CI: 0.93-1.02, P=0.32).Conclusion: Radiotherapy for breast cancer is not associated with an excess risk of lung cancer. Due to the limited number of studies, further research about lung doses from breast cancer radiotherapy varied substantially worldwide, is suggested to the risk of lung cancer after breast cancer radiotherapy.


Author(s):  
Frances K. Duane ◽  
Amanda Kerr ◽  
Zhe Wang ◽  
Sarah C Darby ◽  
Georgios Ntentas ◽  
...  

2021 ◽  
Author(s):  
Bushra Zareie ◽  
Mohammad Aziz Rasouli ◽  
Jalal Poorolajal

Abstract Background: Epidemiological studies have shown that the risk of secondary malignancies may increase by radiotherapy. Lung cancer is the most important long-term complication of breast cancer radiotherapy.Methods: Major electronic databases including Scopus, Web of Science, and MEDLINE were searched. All cohort studies that investigated the association between radiotherapy for breast cancer and risk of primary lung, bronchus and trachea cancers conducted until March 2021 were included. The study participants were evaluated regardless of their age and ethnicity. The Newcastle-Ottawa Scale was used to assess the quality of the studies. The designated effects were risk ratio (RR). The random-effects model was used to estimate the average effects.Results: Fifteen studies including 1,640,247 women with primary breast cancer were identified of which 937,151 had not received radiotherapy and 703,096 subjects had received radiotherapy. In general, there was no significant association between breast cancer radiotherapy and lung cancer based on 10 studies (RR=0.95, 95% CI: 0.87-1.02, P=0.15), There was no association between breast cancer radiotherapy and lung, bronchus, and trachea cancers either based on 5 studies (RR=0.98, 95% CI: 0.93-1.02, P=0.32).Conclusion: Radiotherapy for breast cancer is not associated with an excess risk of lung cancer. Due to the limited number of studies, further research about lung doses from breast cancer radiotherapy varied substantially worldwide, is suggested to the risk of lung cancer after breast cancer radiotherapy.


Sign in / Sign up

Export Citation Format

Share Document